Nippon Life India AMC Intrinsic Value
NAM-INDIA • Capital Markets
Current Stock Price
₹903.20
Primary Intrinsic Value
₹270.96
Market Cap
₹573.5K Cr
-70.0%
Downside
Median Value
₹270.96
Value Range
₹181 - ₹452
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%
NAM-INDIA Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹270.96 | ₹216.77 - ₹325.15 | -70.0% | EPS: ₹21.68, Sector P/E: 12x |
| Book Value Method | asset | ₹180.64 | ₹162.58 - ₹198.70 | -80.0% | Book Value/Share: ₹66.35, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹270.96 | ₹243.86 - ₹298.06 | -70.0% | Revenue/Share: ₹43.78, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹361.28 | ₹325.15 - ₹397.41 | -60.0% | EBITDA: ₹1864.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹361.28 | ₹289.02 - ₹433.54 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹270.96 | ₹243.86 - ₹298.06 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹270.96 | ₹243.86 - ₹298.06 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹451.60 | ₹406.44 - ₹496.76 | -50.0% | ROE: 32.8%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹270.96 | ₹243.86 - ₹298.06 | -70.0% | EPS: ₹21.68, BVPS: ₹66.35 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
NAM-INDIA Intrinsic Value Analysis
What is the intrinsic value of NAM-INDIA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Nippon Life India AMC (NAM-INDIA) is ₹270.96 (median value). With the current market price of ₹903.20, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹180.64 to ₹451.60, indicating ₹180.64 - ₹451.60.
Is NAM-INDIA undervalued or overvalued?
Based on our multi-method analysis, Nippon Life India AMC (NAM-INDIA) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.28 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 32.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 65.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.60x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Nippon Life India AMC
Additional stock information and data for NAM-INDIA
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹1,200 Cr | ₹1,159 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹778 Cr | ₹726 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹587 Cr | ₹587 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹580 Cr | ₹518 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹456 Cr | ₹255 Cr | Positive Free Cash Flow | 8/10 |